<DOC>
	<DOC>NCT00801437</DOC>
	<brief_summary>This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma</brief_summary>
	<brief_title>Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With XalacomÂ® After Failure of Previous Antiglaucoma Therapy.</brief_title>
	<detailed_description>according to physicians decision, patients who met inclusion and exclusion criteria and sign the ICD</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>primary open angle glaucoma ocular hypertension age &gt;18 years bradycardia obstructive pulmonary disease hypersensitivity to the drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>glaucoma, open-angle, non-interventional study, safety, tolerability</keyword>
</DOC>